Dallas, TX -- (SBWIRE) -- 07/29/2015 -- As air pollution worsens, the incidence of respiratory disease keeps growing and so does the market size of relevant drugs. Bromhexine, a semisynthetic derivative of vasicine, is a mucolytic agent used in the treatment of chronic bronchitis and asthma associated with viscid or excessive mucus. It can make the phlegm thinner and less viscous by splitting polysaccharides and cellulose in mucus. Bromhexine is contained in various formulations like tablets and injections. View complete report at http://www.rnrmarketresearch.com/investigation-report-on-china-bromhexine-market-2010-2019-market-report.html
Bromhexine, an effective ingredient of Adhatoda vasica Nees which is an Indian folk expectorant, was first synthesized by Keck in 1963 and came into the market in many countries like Germany, Italy, Britain and France in 1965. In 1973, bromhexine began its production in China and has been written into the Chinese pharmacopoeia.
In recent years, bromhexine develops fast in China with annual sales rising from less than CNY 4 million in 2005 to CNY 87.44 million in 2014 and CAGR during this period reaching up to 41%. Currently, bromhexine in the Chinese market mainly comes from local enterprises like Jiangxi Kelun Pharmaceutical Co., Ltd, Jincheng Haisi Pharmaceutical Co., Ltd and Shanxi Powerdone Pharmaceutical Co., Ltd, Shijiazhuang No.4 Pharmaceutical Co., Ltd and Ma' anshan BBCA Pharmaceutical Co., Ltd, among which Jiangxi Kelun Pharmaceutical Co., Ltd has the largest market share of 32% for sales value in 2014. The market size of bromhexine is expected to grow further in the next few years in China.
Companies Mentioned: Jiangxi Kelun Pharmaceutical Co., Ltd; Jincheng Haisi Pharmaceutical Co., Ltd; Shanxi Powerdone Pharmaceutical Co., Ltd; Shijiazhuang No.4 Pharmaceutical Co., Ltd; Ma'anshan BBCA Pharmaceutical Co., Ltd
Order a copy of this report at http://www.rnrmarketresearch.com/contacts/purchase?rname=396967
Readers can get at least the following information from this report:
- market size of bromhexine in China
- competitive landscape of bromhexine in Chinese market
- price of bromhexine made by different enterprises in China
- market outlook of bromhexine in China
The author suggests the following groups of people purchase this report:
- manufacturers of respiratory drugs
- investors/ research institutions interested in Chinese medicine market
- any interest in the Chinese medicine market, please contact CRI for customized survey service
Table of Contents
1 Related Concepts of Bromhexine
1.1 Indication
1.2 Sales Status in Global Market
2 Market Profile of Bromhexine in China
2.1 Patent and Approval Status of Bromhexine in China
2.2 Major Manufacturers
2.3 Market Size
3 Survey on Sales Status of Bromhexine in China, 2010-2014
3.1 Sales Value
3.1.1 Overall Sales Value
3.1.2 Sales Value by Regions
3.2 Sales Volume
3.2.1 Overall Sales Volume
3.2.2 Sales Volume by Regions
4 Survey on Market Share of Major Manufacturers of Bromhexine in China, 2010-2014
4.1 Market Share by Sales Value
4.2 Market Share by Sales Volume
5 Survey on Dosage Forms of Bromhexine in China, 2010-2014
5.1 Share of Different Dosage Forms by Sales Value
5.2 Share of Different Dosage Forms by Sales Volume
6 Reference Price of Bromhexine in Chinese Hospitals in 2014
6.1 Shanghai Sine Tianping Pharmaceutical Co., Ltd
6.2 Shanghai Xudong Haipu Pharmaceutical Co., Ltd
6.3 Jincheng Haisi Pharmaceutical Co., Ltd (Trade Name: Tanpingshu)
6.4 Shanxi Powerdone Pharmaceutical Co., Ltd
6.5 Shanxi Powerdone Pharmaceutical Co., Ltd
6.6 Wanbangde Pharmaceutical Group Co., Ltd (Trade Name: Bisolvon)
6.7 Shijiazhuang No.4 Pharmaceutical Co., Ltd
6.8 Ma' anshan BBCA Pharmaceutical Co., Ltd (Trade Name: Hekedisi)
7 Major Manufacturers of Bromhexine in Chinese Market, 2010-2014
7.1 Jiangxi Kelun Pharmaceutical Co., Ltd
7.2 Jincheng Haisi Pharmaceutical Co., Ltd
7.3 Shanxi Powerdone Pharmaceutical Co., Ltd
7.4 Shijiazhuang No.4 Pharmaceutical Co., Ltd
7.5 Ma' anshan BBCA Pharmaceutical Co., Ltd
8 Market Outlook of Bromhexine in China, 2015-2019
8.1 Forecast of Market Size
8.2 Forecast of Competitive Landscape
Browse more report on "Respiratory therapeutics" on
http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals/therapeutics/respiratory-therapeutics